The Cigna Group
Every calculator, already run for CI
Open the full toolkit →You have the numbers on CI. Get the argument.
A written report on which of these readings actually decide the outcome for The Cigna Group, what has to stay true for the price to work, and the specific thing that would break it. The first one is free.
Key market data
Analyst consensus
25 analysts covering CIAnalyst Price Target Disagreement for The Cigna Group
Wall Street's bull case implies +45% from the current price; the bear case implies +5%. A 40% spread signals high analyst disagreement — run your own DCF to anchor on fundamentals rather than street consensus.
Ownership & short interest
Insider Trading Activity for CI
| Insider | Role | Type | Shares | Price | Value | Date | Filing |
|---|---|---|---|---|---|---|---|
About The Cigna Group
The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. It operates through two segments: Evernorth Health Services and Cigna Healthcare. The Evernorth Health Services segment includes Pharmacy Benefit Services and Specialty and Care Services, offering pharmacy benefit management, drug claim adjudication, retail pharmacy network administration, benefit design consultation, drug utilization review, drug formulary management, pharmacy benefits, home delivery pharmacy, specialty pharmacy, specialty pharmaceutical distribution, and clinical programs for whole-person health outcomes. The Cigna Healthcare segment comprises U.S. He…
CI — frequently asked
Is CI a buy right now?
Wall Street's consensus rating on The Cigna Group is Buy across 25 analysts, with a mean price target of $339.36 (+23% vs. the current $275.28). Ratings are a starting point — run the DCF and check the financial-health readings above before deciding.
Is CI overvalued?
CI trades at 11.4x trailing earnings, against a DCF fair value of $1173 per share. The current price implies -10% annual free-cash-flow growth for a decade. Open the DCF or reverse-DCF tool to change the assumptions and see the range.
When is CI's next earnings date?
The Cigna Group is next scheduled to report earnings around Nov 5, 2026. A full CI research report from Basis Report covers the setup into that print — estimates, the beat/miss record, and what would move the thesis.
What is the analyst price target disagreement for The Cigna Group?
Analysts covering The Cigna Group (CI) range from a bear-case target of $290.00 to a bull-case high of $400.00, with a mean consensus target of $339.36 across 25 analysts. The spread of $110.00 (40% of the current price) indicates high disagreement on the outlook. Run the DCF calculator to build your own estimate independent of street consensus.
Compare The Cigna Group against related stocks
Explore additional stock overview pages and jump directly into full report generation for each symbol.
Sector peers
Most-followed names in the same sector.
Nearby tickers
Additional public equities from our tracked universe.
Market leaders
Large-cap symbols investors frequently compare.
Investor Guides For The Cigna Group
Start with the evergreen guides that matter most for Healthcare, then move back into the ticker page when you want to pressure-test the framework on a live name.
Generate your full CI research report
DCF model, five-year financials, moat assessment, a BUY/HOLD/SELL rating, and the risks that matter — on The Cigna Group, in minutes. 3 free reports included with every account — no credit card required.